We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$861M
AUM Growth
+$133M
Cap. Flow
+$160M
Cap. Flow %
18.6%
Top 10 Hldgs %
8.61%
Holding
2,375
New
954
Increased
318
Reduced
326
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 12.03%
2 Industrials 9.36%
3 Financials 8.51%
4 Consumer Discretionary 7.02%
5 Healthcare 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CURV icon
1351
Torrid Holdings
CURV
$254M
$23.5K ﹤0.01%
+13,209
New +$16.3K
SMXT icon
1352
Solarmax Technology
SMXT
$19.6M
$23.5K ﹤0.01%
33,522
+14,675
+78% +$11.4K
CHGG icon
1353
Chegg
CHGG
$110M
$23.3K ﹤0.01%
+31,495
New +$22.1K
NNOX icon
1354
Nano X Imaging
NNOX
$68.2M
$23.3K ﹤0.01%
10,258
-2,993
-23% -$7.87K
PSTV icon
1355
Plus Therapeutics
PSTV
$26.6M
$23.2K ﹤0.01%
5,712
+3,477
+156% +$26.4K
KPRX icon
1356
Kiora Pharmaceuticals
KPRX
$11.3M
$23.2K ﹤0.01%
+12,019
New +$25.4K
ELBM
1357
Electra Battery Materials
ELBM
$54.9M
$22.4K ﹤0.01%
40,023
+28,181
+238% +$22.9K
SHFS icon
1358
SHF Holdings
SHFS
$1.19M
$22.3K ﹤0.01%
+26,830
New +$26.2K
DFNS
1359
T3 Defense Inc
DFNS
$28M
$22.2K ﹤0.01%
+248
New +$67.2K
ALXO icon
1360
ALX Oncology
ALXO
$261M
$22K ﹤0.01%
+10,993
New +$20.9K
ONCY
1361
Oncolytics Biotech
ONCY
$89.9M
$21.8K ﹤0.01%
+25,627
New +$25.5K
BYND icon
1362
Beyond Meat
BYND
$292M
$21.7K ﹤0.01%
+30,932
New +$24.7K
OMEX icon
1363
Odyssey Marine Exploration
OMEX
$34.9M
$21.5K ﹤0.01%
+25,806
New +$43.8K
FLNA
1364
Filana Therapeutics
FLNA
$48.8M
$21.5K ﹤0.01%
+12,696
New +$26.1K
CRDF icon
1365
Cardiff Oncology
CRDF
$66.5M
$21.2K ﹤0.01%
+13,102
New +$26.9K
BNGO icon
1366
Bionano Genomics
BNGO
$12.3M
$21.1K ﹤0.01%
+18,056
New +$23.1K
DVLT
1367
Datavault AI
DVLT
$291M
$21K ﹤0.01%
34,042
+18,686
+122% +$14.2K
DOGZ icon
1368
Dogness International Corp
DOGZ
$12.8M
$20.8K ﹤0.01%
+14,520
New +$55.8K
TOVX icon
1369
Theriva Biologics
TOVX
$9.64M
$20.6K ﹤0.01%
105,241
+62,348
+145% +$12.3K
ABVC icon
1370
ABVC BioPharma
ABVC
$26.3M
$20.4K ﹤0.01%
+21,023
New +$34.8K
CELU icon
1371
Celularity
CELU
$18.4M
$19.8K ﹤0.01%
+14,866
New +$18.8K
PYXS icon
1372
Pyxis Oncology
PYXS
$168M
$19.7K ﹤0.01%
+13,474
New +$20.3K
CHAI
1373
Core AI Holdings Inc
CHAI
$8.54M
$19.7K ﹤0.01%
+19,473
New +$33.8K
GWH icon
1374
ESS Tech
GWH
$22M
$19.4K ﹤0.01%
+16,592
New +$25.6K
NMTC icon
1375
NeuroOne Medical Technologies
NMTC
$14.7M
$19.2K ﹤0.01%
+4,127
New +$19.8K

Similar funds

Two Sigma Securities's Q1 2026 Portfolio in Review

As of Q1 2026, Two Sigma Securities held 2,375 positions worth $861M, up 18% from $728M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Two Sigma Securities deployed $160M of net new capital in Q1 2026, opening 954 new positions and adding to 318 existing holdings. Its largest new stake was Direxion Daily Semiconductor Bull 3X ETF: 168,582 shares worth $8.08M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $14.3M trimmed.

  • Two Sigma Securities's largest Q1 2026 buy was Direxion Daily Semiconductor Bull 3X ETF: 168,582 shares worth $8.08M.
  • Two Sigma Securities added most to iShares Core US Aggregate Bond ETF in Q1 2026, an estimated $12M increase.
  • Two Sigma Securities's biggest Q1 2026 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $14.3M.
  • Two Sigma Securities fully exited Microsoft in Q1 2026, selling an estimated $12.3M.
  • Two Sigma Securities's ten largest holdings make up 8.6% of its $861M portfolio in Q1 2026.
  • Two Sigma Securities opened 954 new positions and closed 776 in Q1 2026.
  • Two Sigma Securities's portfolio value rose 18% quarter-over-quarter to $861M.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.